1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

venBio Select Advisor LLC Buys MyoKardia Inc, Amarin Corp PLC, Array BioPharma Inc, Sells Loxo Oncology Inc, TG Therapeutics Inc, PTC Therapeutics Inc

San Francisco, CA, based Investment company venBio Select Advisor LLC buys MyoKardia Inc, Amarin Corp PLC, Array BioPharma Inc, The Medicines Co, ACADIA Pharmaceuticals Inc, Global Blood Therapeutics Inc, BioDelivery Sciences International Inc, Madrigal Pharmaceuticals Inc, CymaBay Therapeutics Inc, sells Loxo Oncology Inc, TG Therapeutics Inc, PTC Therapeutics Inc, Y-mAbs Therapeutics Inc, Proteostasis Therapeutics Inc, Acer Therapeutics Inc during the 3-months ended 2019Q1, according to the most recent filings of the investment company, venBio Select Advisor LLC. As of 2019Q1, venBio Select Advisor LLC owns 29 stocks with a total value of $2.3 billion. These are the details of the buys and sells.

For the details of venBio Select Advisor LLC's stock buys and sells, go to https://www.gurufocus.com/guru/venbio+select+advisor+llc/current-portfolio/portfolio

These are the top 5 holdings of venBio Select Advisor LLC
  1. Immunomedics Inc (IMMU) - 17,714,461 shares, 14.94% of the total portfolio.
  2. Mirati Therapeutics Inc (MRTX) - 3,862,500 shares, 12.43% of the total portfolio. Shares reduced by 19.5%
  3. Ascendis Pharma A/S (ASND) - 1,795,000 shares, 9.27% of the total portfolio. Shares reduced by 9.34%
  4. Amarin Corp PLC (AMRN) - 8,000,000 shares, 7.29% of the total portfolio. Shares added by 43.50%
  5. Sarepta Therapeutics Inc (SRPT) - 1,195,000 shares, 6.25% of the total portfolio. Shares reduced by 6.27%
New Purchase: MyoKardia Inc (MYOK)

venBio Select Advisor LLC initiated holding in MyoKardia Inc. The purchase prices were between $39.23 and $55.82, with an estimated average price of $46.05. The stock is now traded at around $50.14. The impact to a portfolio due to this purchase was 2.28%. The holding were 1,000,000 shares as of .

New Purchase: Array BioPharma Inc (ARRY)

venBio Select Advisor LLC initiated holding in Array BioPharma Inc. The purchase prices were between $14.25 and $24.45, with an estimated average price of $20.7. The stock is now traded at around $46.33. The impact to a portfolio due to this purchase was 2.14%. The holding were 2,000,000 shares as of .

New Purchase: The Medicines Co (MDCO)

venBio Select Advisor LLC initiated holding in The Medicines Co. The purchase prices were between $17.86 and $28.02, with an estimated average price of $23.46. The stock is now traded at around $36.47. The impact to a portfolio due to this purchase was 1.92%. The holding were 1,562,000 shares as of .

New Purchase: ACADIA Pharmaceuticals Inc (ACAD)

venBio Select Advisor LLC initiated holding in ACADIA Pharmaceuticals Inc. The purchase prices were between $16.17 and $27.38, with an estimated average price of $23.2. The stock is now traded at around $26.73. The impact to a portfolio due to this purchase was 1.56%. The holding were 1,325,000 shares as of .

New Purchase: CymaBay Therapeutics Inc (CBAY)

venBio Select Advisor LLC initiated holding in CymaBay Therapeutics Inc. The purchase prices were between $7.87 and $13.42, with an estimated average price of $10.56. The stock is now traded at around $7.16. The impact to a portfolio due to this purchase was 0.42%. The holding were 725,000 shares as of .

Added: Amarin Corp PLC (AMRN)

venBio Select Advisor LLC added to a holding in Amarin Corp PLC by 43.50%. The purchase prices were between $12.61 and $22.33, with an estimated average price of $17.95. The stock is now traded at around $19.39. The impact to a portfolio due to this purchase was 2.21%. The holding were 8,000,000 shares as of .

Added: Global Blood Therapeutics Inc (GBT)

venBio Select Advisor LLC added to a holding in Global Blood Therapeutics Inc by 171.43%. The purchase prices were between $39.99 and $53.48, with an estimated average price of $49.06. The stock is now traded at around $52.60. The impact to a portfolio due to this purchase was 1.4%. The holding were 950,000 shares as of .

Added: BioDelivery Sciences International Inc (BDSI)

venBio Select Advisor LLC added to a holding in BioDelivery Sciences International Inc by 57.14%. The purchase prices were between $3.65 and $5.3, with an estimated average price of $4.55. The stock is now traded at around $4.65. The impact to a portfolio due to this purchase was 0.63%. The holding were 7,424,867 shares as of .

Added: Madrigal Pharmaceuticals Inc (MDGL)

venBio Select Advisor LLC added to a holding in Madrigal Pharmaceuticals Inc by 37.78%. The purchase prices were between $103.48 and $143.84, with an estimated average price of $124.23. The stock is now traded at around $104.81. The impact to a portfolio due to this purchase was 0.47%. The holding were 310,000 shares as of .

Sold Out: Loxo Oncology Inc (LOXO)

venBio Select Advisor LLC sold out a holding in Loxo Oncology Inc. The sale prices were between $131.02 and $234.75, with an estimated average price of $222.49.

Sold Out: TG Therapeutics Inc (TGTX)

venBio Select Advisor LLC sold out a holding in TG Therapeutics Inc. The sale prices were between $4.02 and $8.04, with an estimated average price of $5.36.

Sold Out: PTC Therapeutics Inc (PTCT)

venBio Select Advisor LLC sold out a holding in PTC Therapeutics Inc. The sale prices were between $28.09 and $39.49, with an estimated average price of $33.54.

Sold Out: Y-mAbs Therapeutics Inc (YMAB)

venBio Select Advisor LLC sold out a holding in Y-mAbs Therapeutics Inc. The sale prices were between $18.21 and $26.21, with an estimated average price of $21.95.

Sold Out: Proteostasis Therapeutics Inc (PTI)

venBio Select Advisor LLC sold out a holding in Proteostasis Therapeutics Inc. The sale prices were between $1.24 and $4.46, with an estimated average price of $3.49.

Sold Out: Acer Therapeutics Inc (ACER)

venBio Select Advisor LLC sold out a holding in Acer Therapeutics Inc. The sale prices were between $20.12 and $25.15, with an estimated average price of $23.57.



Here is the complete portfolio of venBio Select Advisor LLC. Also check out:

1. venBio Select Advisor LLC's Undervalued Stocks
2. venBio Select Advisor LLC's Top Growth Companies, and
3. venBio Select Advisor LLC's High Yield stocks
4. Stocks that venBio Select Advisor LLC keeps buying

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:



Performances of the stocks mentioned by insider


User Generated Screeners


pjmason14Momentum
pascal.van.garsseHigh FCF-M2
kosalmmuse6
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
kosalmmuseNice
kosalmmusehan
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)